Literature DB >> 10486428

Physico-chemical characterization of interactions between erythromycin and various film polymers.

N Sarisuta1, M Kumpugdee, B W Müller, S Puttipipatkhachorn.   

Abstract

In this study the interactions between erythromycin and various polymers (Eudragit L100, shellac, polyvinyl acetate phthalate (PVAP), cellulose acetate phthalate (CAP), hydroxypropyl methylcellulose acetate phthalate (HPMCP), and hydroxypropyl methylcellulose (HPMC)) were investigated. The polymer films containing drugs were prepared and characterized by the use of infrared spectroscopy, powder X-ray diffraction analysis, thermal analysis, thin layer chromatography, and nuclear magnetic resonance (NMR) spectroscopy. Preliminary studies of pure drug powders recrystallized in various organic solvent systems suggested a mixture of amorphous and crystalline forms whereas those recrystallized in water and organic solvent-water mixture led to the dihydrate form. Erythromycin in drug-polymer mixtures exhibited molecular dispersions in all six polymers studied. The amine salt interaction between the carboxyl group of the acid polymers and N-atom of erythromycin was indicated by the NMR technique. The solid solution of erythromycin in all polymer films studied was physically stable under stress conditions (8 degrees C/3 days and 40 degrees C/3 days for six cycles).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10486428     DOI: 10.1016/s0378-5173(99)00140-4

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Influence of solvents on the variety of crystalline forms of erythromycin.

Authors:  Sabiruddin Mirza; Inna Miroshnyk; Jyrki Heinämäki; Leena Christiansen; Milja Karjalainen; Jouko Yliruusi
Journal:  AAPS PharmSci       Date:  2003

2.  Evaluation of the drug solubility and rush ageing on drug release performance of various model drugs from the modified release polyethylene oxide matrix tablets.

Authors:  Saeed Shojaee; Ali Nokhodchi; Mohammed Maniruzzaman
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 5.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.